How Much Does PGT Cost in the United States, and Which Embryo Testing Fees Are Often Not Included in IVF Quotes?

As a reproductive medicine physician, I often meet patients who have carefully compared IVF prices between clinics, only to discover later that “IVF with PGT” does not always mean one bundled price. One clinic may quote egg retrieval, fertilization, embryo culture, embryo biopsy, genetic testing, and the first frozen embryo transfer as separate line items. Another clinic may show a package price but exclude medication, anesthesia, embryo storage, PGT lab fees, or the cost of testing more than a small number of embryos. A third clinic may include the embryo biopsy fee but not the genetic laboratory analysis fee. This is why two quotes that appear to differ by only a few thousand dollars can become very different once all embryo testing-related charges are added.

In the United States, the total cost of PGT varies widely, but a practical planning range is often $3,000 to $7,500 or more in addition to the base IVF cycle cost. Some patients pay less, especially if only one or two embryos are tested and the clinic has a bundled contract with a genetics lab. Others pay more, particularly when many embryos are biopsied, when PGT-M for a single-gene disorder is needed, when custom test development is required, or when embryos must be transported between facilities. The key point is that “PGT cost” is not one single fee. It is a collection of services that occur before, during, and after embryo testing.

What Is PGT, and Why Does the Type of Testing Matter for Cost?

PGT stands for preimplantation genetic testing. It is performed during an IVF cycle, usually after embryos have grown in the laboratory to the blastocyst stage, commonly day 5, day 6, or sometimes day 7. A few cells are removed from the outer layer of the embryo, called the trophectoderm, which later contributes to the placenta. The embryo is usually frozen after biopsy while the sample is sent to a genetic testing laboratory. Once results return, the fertility team and patient decide which embryo, if any, is appropriate for transfer.

There are several types of PGT, and each has a different purpose and cost structure:

Most patients asking about PGT cost are referring to PGT-A, because it is the most commonly offered type of embryo testing in IVF clinics. PGT-A is often discussed for patients of advanced reproductive age, those with recurrent pregnancy loss, repeated implantation failure, severe male factor infertility, or patients who wish to reduce the risk of transferring an embryo with a major chromosomal imbalance. However, PGT-A is not the right choice for everyone, and it does not guarantee pregnancy, live birth, or a genetically “normal” baby. It also cannot screen for every genetic or developmental condition.

PGT-M and PGT-SR are different. These are often medically indicated when there is a known genetic risk in the family. For example, if both partners are carriers of the same autosomal recessive condition, or one partner has a dominant disease-causing variant, PGT-M may help identify embryos that are not affected by that specific condition. The cost is higher because the laboratory often needs DNA samples from the intended parents and sometimes other relatives to build or validate a custom test. This “test development” step can add both cost and time before IVF begins.

Typical PGT-A Costs in the United States

For PGT-A in the United States, many patients should expect a combined cost of approximately $3,000 to $6,000 for embryo biopsy and genetic analysis, although prices can fall outside this range. Some clinics quote embryo biopsy separately from the genetic laboratory fee. Others include biopsy in an IVF package but require the patient to pay the genetic lab directly. The number of embryos matters greatly. A patient testing one embryo may pay far less than a patient testing twelve embryos.

The following table shows a realistic, simplified example of how PGT-A costs may be presented. These are estimates, not universal prices:

A common scenario is that a clinic charges a biopsy fee of around $2,000 to $3,000, while the genetic testing laboratory charges separately for each embryo or for a batch of embryos. For example, a patient may pay $2,500 to the clinic for biopsy and $2,000 to the genetics lab to test up to eight embryos. If there are more than eight embryos, there may be a per-embryo surcharge. In another clinic, the quote might say “PGT-A: $4,500,” but the fine print may reveal that shipping, counseling, storage, and future embryo transfer are not included.

Typical PGT-M and PGT-SR Costs

PGT-M and PGT-SR are usually more expensive than PGT-A because they require more individualized laboratory preparation. For PGT-M, the lab must know exactly what genetic variant is being tested. The intended parents usually need prior genetic testing, and sometimes samples from relatives are requested. The lab then creates or validates a customized method to track the disease-related variant and surrounding genetic markers in embryos. This process may take several weeks to several months.

In the United States, a rough planning range for PGT-M is often $5,000 to $12,000 or more on top of the standard IVF cycle, depending on the condition, laboratory, number of embryos, and whether a custom probe or test development is required. Some patients pay a one-time test development fee, then a separate per-embryo testing fee. Others pay a combined package that includes test development and analysis of a certain number of embryos. If another IVF cycle is needed later, the lab may charge a lower repeat-testing fee, but this is not guaranteed.

PGT-SR may fall somewhere between PGT-A and PGT-M in cost, but it depends on the complexity of the chromosomal rearrangement and the laboratory method used. Some labs combine PGT-SR with PGT-A, while others price it differently. Patients with translocations or inversions should ask whether the quoted price includes chromosome copy number analysis, structural rearrangement assessment, genetic counseling, and any necessary parental chromosome reports.

Why IVF Quotes Often Do Not Include All PGT-Related Fees

IVF pricing in the United States is fragmented because care is delivered by multiple teams. Your fertility clinic may perform ovarian stimulation monitoring, egg retrieval, fertilization, embryo culture, and embryo transfer. The embryology laboratory may be part of the clinic or a related facility. The genetic testing lab may be an outside company. Medication pharmacies, anesthesia groups, cryostorage facilities, and genetic counselors may bill separately. For this reason, a clinic’s IVF quote may not include every service that occurs during a PGT cycle.

Another reason is that some costs are unpredictable at the start. No one knows exactly how many eggs will be retrieved, how many will fertilize, how many embryos will reach the blastocyst stage, or how many embryos will be suitable for biopsy. A patient may expect to test six embryos but end up testing none, one, or twelve. If a quote included unlimited testing, it would need to be priced higher for everyone. Instead, many clinics list estimated fees and then reconcile the final cost based on the actual number of embryos biopsied.

Some clinics also use package pricing for marketing simplicity. A website may advertise “IVF starting at $12,000” or “IVF package $15,000,” but that package may exclude medications, anesthesia, embryo freezing, embryo storage, embryo biopsy, PGT laboratory fees, frozen embryo transfer, and pregnancy monitoring. The headline number is not necessarily misleading, but it is incomplete if the patient is planning PGT.

Embryo Testing Fees Often Not Included in IVF Quotes

The most important financial step is to ask for a written, itemized estimate before starting stimulation. Below are the embryo testing-related fees that are commonly missing from basic IVF quotes or only partially included.

The Difference Between Biopsy Fees and Genetic Testing Fees

One of the most common misunderstandings is the difference between the embryo biopsy fee and the genetic testing fee. The biopsy fee belongs to the IVF laboratory process. It pays for embryology expertise, equipment, culture conditions, micromanipulation tools, laser use when applicable, sample preparation, and coordination with cryopreservation. The genetic testing fee belongs to the genetics laboratory. It pays for DNA amplification, sequencing or array-based analysis, quality control, interpretation, reporting, and sometimes genetic counselor support.

If a clinic says “PGT biopsy included,” that does not automatically mean the genetic lab’s analysis is included. Conversely, if a genetics lab quotes a price for PGT-A, that may not include the clinic’s biopsy fee. Patients should specifically ask: “Does this price include both biopsy and genetic analysis?” If the answer is no, request both numbers in writing.

Embryo Freezing, Storage, and Frozen Transfer Costs

PGT usually changes the structure of an IVF cycle. In a non-PGT cycle, some patients may have a fresh embryo transfer a few days after retrieval, although frozen transfers are now very common even without PGT. In a PGT cycle, embryos are typically biopsied and then frozen because results are not usually available immediately. That means the patient should expect charges related to embryo vitrification, embryo storage, and a future frozen embryo transfer.

Embryo freezing may cost anywhere from several hundred dollars to more than $2,000 depending on the clinic and what is included. Annual storage commonly ranges from about $500 to $1,200, though some facilities charge more. A frozen embryo transfer cycle may cost approximately $3,000 to $7,000 before medications, depending on monitoring, ultrasound, bloodwork, laboratory thawing, transfer procedure, and physician fees. Some IVF packages include the first frozen transfer; many do not.

This is especially important when comparing a fresh-transfer IVF quote with a PGT-based IVF plan. If the PGT plan requires freezing and later transfer, the total cost may include an additional cycle of monitoring and medications. Patients should ask whether the quoted price ends at egg retrieval, ends at embryo freezing, or includes embryo transfer and pregnancy test.

Medication, Anesthesia, and Other IVF Costs That Affect the Total Bill

Although medications and anesthesia are not embryo testing fees, they strongly affect the total cost of an IVF cycle with PGT. Injectable stimulation medications may cost approximately $3,000 to $8,000 or more, depending on ovarian reserve, dose, pharmacy pricing, and insurance coverage. Some patients with diminished ovarian reserve require high doses; others need lower doses. Medication costs are often paid directly to a specialty pharmacy and may not appear in the clinic’s IVF quote.

Anesthesia for egg retrieval may be included in some clinics’ procedure fee, but in many centers it is billed separately by an anesthesia group. This may add several hundred to over a thousand dollars. Pre-cycle testing, infectious disease labs, saline sonogram, mock transfer, semen analysis, sperm freezing, ICSI, assisted hatching, donor sperm preparation, and pregnancy monitoring may also be separate line items. When PGT is added, the final bill can feel surprising unless the patient has reviewed the entire IVF pathway rather than only the embryo testing fee.

How the Number of Embryos Changes PGT Cost

PGT cost is closely tied to the number of embryos that reach the biopsy stage. This number cannot be predicted perfectly. Age, ovarian reserve, sperm quality, egg quality, stimulation response, fertilization method, embryo culture conditions, and chance all play roles. A younger patient or an egg donor cycle may produce many blastocysts, increasing the testing bill. A patient with low ovarian reserve may produce no embryos suitable for testing, in which case some testing fees may not apply, although the IVF cycle itself has still occurred.

Here is a simplified example:

Patients sometimes ask whether they can choose to test only some embryos to reduce cost. In some cases this may be possible, but it requires careful discussion with the physician and embryology team. The decision may depend on embryo quality, age, family-building goals, whether PGT-M is involved, and whether untested embryos will be stored separately or considered for later transfer. Testing only part of an embryo cohort can create future decision-making complexity, especially if tested embryos do not lead to pregnancy and untested embryos remain.

Insurance Coverage for PGT in the United States

Insurance coverage for IVF and PGT varies dramatically in the United States. Some states have infertility insurance mandates, but mandates differ in who qualifies, what services are included, whether IVF is covered, and whether genetic testing is covered. Employer-sponsored plans may cover IVF but exclude PGT-A as “elective” or “not medically necessary.” Some plans may cover PGT-M when there is a documented risk of a serious inherited condition. Others may deny all embryo testing charges.

Even when IVF is covered, patients should not assume that PGT is covered. It is common for insurance to cover monitoring and retrieval but not embryo biopsy or genetic lab analysis. Some genetic labs will bill insurance, while others require self-pay and provide a superbill. Prior authorization may be needed. Patients using insurance should ask for procedure codes, diagnosis codes, preauthorization requirements, and written confirmation of benefits. Verbal benefit checks are helpful but not always reliable.

If PGT-M is being considered for a known genetic disorder, documentation from a genetic counselor or medical geneticist may improve the chance of coverage. This may include carrier screening results, diagnostic genetic reports, family history, and a letter of medical necessity. However, approval is never guaranteed, and the patient should ask what happens financially if insurance denies the claim after testing has already been performed.

Does PGT Save Money by Reducing Miscarriage or Failed Transfers?

This is an understandable question, but the answer is not the same for every patient. PGT-A may reduce the chance of transferring an embryo with an abnormal chromosome number, and in some groups it may reduce miscarriage risk or shorten time to pregnancy by helping select embryos with a higher implantation potential. However, PGT-A does not create healthy embryos, does not improve egg quality, and does not guarantee a live birth. The financial benefit depends on the patient’s age, number of embryos, prior history, clinic success rates, cost of transfers, and the likelihood that PGT results will change management.

For example, a 40-year-old patient with several blastocysts may benefit from knowing which embryos are euploid before transfer, potentially avoiding multiple unsuccessful transfers or miscarriages. On the other hand, a younger patient with one or two embryos may find that PGT-A adds cost and may not clearly improve the chance of live birth per retrieval. Some patients value the information regardless of cost; others prefer to transfer untested embryos. This is a medical and personal decision, not only a financial calculation.

PGT-M is different because the goal is often to avoid passing on a known serious genetic condition. In that context, the value may not be measured only by implantation rates or miscarriage rates. It may be about preventing an affected pregnancy or reducing the need for prenatal diagnostic decisions later. Still, prenatal testing during pregnancy, such as chorionic villus sampling or amniocentesis, may still be recommended because PGT is highly informative but not considered a perfect substitute for prenatal diagnosis.

What Happens If PGT Results Are Inconclusive?

Occasionally, an embryo biopsy result returns as “no result,” “no call,” or inconclusive. This can occur if there is insufficient DNA, amplification failure, sample quality issues, or technical limitations. The clinic may discuss options: transferring the embryo as untested, keeping it frozen, or thawing, re-biopsying, and refreezing it. Re-biopsy can provide more information but may involve additional cost and possible risk to embryo survival. Not every embryo is a good candidate for re-biopsy.

Patients should ask in advance how the clinic and lab handle inconclusive results. Is repeat testing free, discounted, or fully charged? Does the genetic lab waive the fee if the failure is technical? Does the clinic charge again for thawing, biopsy, and refreezing? These policies vary. Because no-call results are uncommon but emotionally significant, it is better to understand the policy before embryos are tested.

Embryo Transport Fees and Outside Lab Coordination

Some patients already have frozen embryos at one clinic and want PGT performed later. This may require transporting embryos to a facility that can thaw, biopsy, refreeze, and send samples to a genetics lab. Embryo transport is more complex than shipping a blood sample. It requires specialized cryogenic shipping tanks, chain-of-custody documentation, consent forms, receiving lab coordination, and sometimes medical record review. Transport can cost hundreds to thousands of dollars depending on distance and service type.

If embryos are moved between clinics, additional administrative fees may apply. The receiving clinic may charge for embryo intake, infectious disease documentation review, tank handling, thawing, biopsy, refreezing, and storage. The original clinic may charge a release or shipping coordination fee. These costs are often not included in standard IVF or PGT quotes because they apply only to certain situations.

How to Compare IVF Clinics When PGT Is Planned

When comparing clinics, do not compare only the advertised IVF price. Instead, compare the full pathway from consultation to pregnancy test. A lower base IVF fee may not be less expensive if it excludes ICSI, embryo biopsy, genetic testing, freezing, storage, and frozen transfer. Conversely, a higher package price may be reasonable if it includes many services that other clinics bill separately.

Ask each clinic for the same scenario: “If I do one egg retrieval, use ICSI, grow embryos to blastocyst, biopsy all suitable embryos for PGT-A, freeze embryos, test up to eight embryos, store them for one year, and later do one frozen embryo transfer, what is the estimated total self-pay cost including clinic, lab, anesthesia, storage, and outside genetic lab fees?” This question forces the quote to reflect the real treatment plan rather than a partial cycle.

Also ask what happens if the cycle outcome is different than expected. What if no embryos reach biopsy? Is any PGT fee refunded? What if more embryos are biopsied than expected? What if the cycle is canceled before retrieval? What if the patient needs a second retrieval before transfer? Good financial counseling should include these possibilities.

Checklist: Questions to Ask Before Paying for PGT

• What type of PGT is being recommended: PGT-A, PGT-M, PGT-SR, or a combination?
• Is embryo biopsy included in the IVF quote?
• Is the genetic laboratory analysis included, or will I receive a separate bill?
• How many embryos are included in the quoted testing price?
• What is the fee for each additional embryo?
• Is sample shipping or courier service included?
• Is genetic counseling required, and is it included?
• If PGT-M is needed, is custom test development included?
• How long does test development take before IVF can begin?
• Are embryo freezing and the first year of storage included?
• Is the frozen embryo transfer included in the IVF package?
• What happens financially if no embryos are available for biopsy?
• What happens if a result is inconclusive or no-call?
• Does the clinic recommend prenatal testing even after PGT?
• Will insurance be billed, and do I need prior authorization?

A Practical Cost Example

Consider a patient paying out of pocket for IVF with PGT-A. The clinic’s base IVF cycle is quoted at $14,000. Medications are estimated at $5,000. Anesthesia is $800. ICSI is $1,500. Embryo biopsy is $2,500. The genetic lab charges $2,200 for up to eight embryos. Embryo freezing is $1,000, one year of storage is $700, and the frozen embryo transfer is $4,500 plus $600 in medications. The advertised IVF price was $14,000, but the realistic total from stimulation through first frozen transfer is closer to $32,800. This does not mean the clinic did anything wrong; it means the original price represented only part of the treatment pathway.

Now imagine another clinic advertises a $22,000 IVF package that includes ICSI, biopsy, freezing, one year of storage, and one frozen transfer, but not medications, anesthesia, or the outside PGT lab fee. If medications are $5,000, anesthesia is $800, and PGT lab analysis is $2,200, the total becomes $30,000. The second clinic looked more expensive at first but may be similar or even less expensive once all line items are considered.

Final Thoughts

In the United States, PGT commonly adds several thousand dollars to the cost of IVF, and the final amount depends on the type of testing, the number of embryos, the clinic’s biopsy fee, the genetic laboratory’s pricing model, and whether related services such as embryo freezing, storage, counseling, shipping, and frozen transfer are included. For PGT-A, many patients should plan for roughly $3,000 to $6,000 or more in PGT-related charges. For PGT-M or complex PGT-SR, costs may be significantly higher, especially when custom test development is required.

The best way to avoid financial surprises is to request a detailed written estimate that separates clinic charges from outside laboratory charges. Ask whether the quote includes embryo biopsy, genetic analysis, shipping, counseling, extra embryos, embryo freezing, storage, and the first frozen embryo transfer. If you are using insurance, confirm coverage before testing begins and ask about prior authorization. Most importantly, discuss whether PGT is medically appropriate for your situation. The most expensive test is not always the best test for every patient, and the right choice should reflect your medical history, age, embryo number, genetic risk, values, and family-building goals.

This article is for general education and does not replace individualized medical, genetic, or financial counseling. PGT pricing and insurance coverage vary widely by clinic, laboratory, state, employer plan, and personal medical situation.